NFSG
FOLD

Newbridge Financial Services Group’s Amicus Therapeutics FOLD Stock Holding History

Newbridge Financial Services Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100
Closed -$1.18K – 1141
2024
Q1 		$1.18K Hold
100
– – ﹤0.01% 1036
2023
Q4 		$1.42K Sell
100
-95
-49% -$1.08K ﹤0.01% 999
2023
Q3 		$2.37K Buy
195
+100
+105% +$1.29K ﹤0.01% 1052
2023
Q2 		$1.19K Hold
95
– – ﹤0.01% 1196
2023
Q1 		$1.05K Hold
95
– – ﹤0.01% 1268
2022
Q4 		$1.16K Hold
95
– – ﹤0.01% 1284
2022
Q3 		$1K Hold
95
– – ﹤0.01% 1293
2022
Q2 		$1K Hold
95
– – ﹤0.01% 1269
2022
Q1 		$1K Hold
95
– – ﹤0.01% 1376
2021
Q4 		$1K Hold
95
– – ﹤0.01% 1325
2021
Q3 		$1K Hold
95
– – ﹤0.01% 1258
2021
Q2 		$1K Hold
95
– – ﹤0.01% 1353
2021
Q1 		$1K Buy
+95
New +$1.47K ﹤0.01% 1271

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Newbridge Financial Services Group's FOLD Position: Q2 2024 in Review

Newbridge Financial Services Group sold out of Amicus Therapeutics (FOLD) in Q2 2024, closing a stake of 100 shares — an estimated $1.18K sold.

Newbridge Financial Services Group first reported a position in FOLD in Q1 2021 and held it in 13 quarters. The position peaked at $2.37K in Q3 2023. 258 funds tracked by Wall St. Rank hold FOLD as of Q2 2024.

  • Newbridge Financial Services Group reported no remaining Amicus Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 100 Amicus Therapeutics shares in Q2 2024, an estimated $1.18K.
  • Newbridge Financial Services Group first reported a position in Amicus Therapeutics in Q1 2021 and held it in 13 quarters.
  • Newbridge Financial Services Group's Amicus Therapeutics position peaked at $2.37K in Q3 2023.
  • 258 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2024.

Based on Newbridge Financial Services Group's 13F filing for Q2 2024, filed 11 Sep 2024.